Viberzi 75 mg (Eluxadoline TABLET) 75 MG

VIBERZI 75 MG tablets contain eluxadoline, a medication used to manage irritable bowel syndrome with diarrhea (IBS-D). This oral treatment is designed to help alleviate symptoms and improve quality of life for those affected by IBS-D.

Strength

75 MG

Manufacturer / TM Owner

ABBVIE CORPORATION

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VIBERZI 75 MG is primarily used for the management of irritable bowel syndrome with diarrhea (IBS-D). This medication works by targeting receptors in the gut to reduce symptoms such as abdominal pain, diarrhea, and urgency. It is specifically formulated for adults experiencing these symptoms, providing a targeted approach to symptom relief.

Side Effects

Common effects of VIBERZI 75 MG may include constipation, nausea, and abdominal pain. Some users may also experience fatigue or dizziness. These effects can vary from person to person, and it's important to monitor how the body responds to the medication.

Precautions & Warnings

VIBERZI 75 MG should be handled with care, especially for individuals with a history of pancreatitis, severe liver impairment, or alcoholism. It is crucial to follow the prescribed guidelines and consult a healthcare provider before starting this medication. Always store the tablets in a cool, dry place away from direct sunlight.

Avoid Interactions

VIBERZI 75 MG may interact with certain medications, including strong CYP2C9 inhibitors and alcohol. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be avoided while using this medication to prevent adverse effects.

Frequently Asked Questions

VIBERZI 75 MG is used to manage irritable bowel syndrome with diarrhea (IBS-D) in adults.

VIBERZI 75 MG is taken orally, typically as directed by a healthcare provider.

Common side effects may include constipation, nausea, abdominal pain, fatigue, and dizziness.

It is recommended to avoid alcohol while taking VIBERZI 75 MG to prevent potential adverse effects.

Individuals with a history of pancreatitis, severe liver impairment, or alcoholism should exercise caution and consult a healthcare provider before taking VIBERZI 75 MG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.